Novel macrolides through genetic engineering
- 10 November 1999
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 19 (6) , 543-558
- https://doi.org/10.1002/(sici)1098-1128(199911)19:6<543::aid-med5>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- In Vitro Susceptibilities of Aerobic and Facultative Non-Spore-Forming Gram-Positive Bacilli to HMR 3647 (RU 66647) and 14 Other AntimicrobialsAntimicrobial Agents and Chemotherapy, 1998
- Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1995
- Antimicrobial resistance: prognosis for public healthTrends in Microbiology, 1994
- Glycopeptide resistance mediated by enterococcal transposon Tn 1546 requires production of VanX for hydrolysis of D‐alanyl‐D‐alanineMolecular Microbiology, 1994
- Livermore Lab Chief Nuckolls Resigns Under PressureScience, 1994
- Genetics and mechanisms of glycopeptide resistance in enterococciAntimicrobial Agents and Chemotherapy, 1993
- Exploring New Strategies to Fight Drug-Resistant MicrobesScience, 1992
- The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147Journal of Bacteriology, 1992
- Resistance of enterococci to glycopeptidesAntimicrobial Agents and Chemotherapy, 1990
- Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A.The Journal of Antibiotics, 1984